STOCK TITAN

Viatris (VTRS) insider trims stake with 21,350-share open-market sale

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Viatris Inc officer Paul Campbell reported an open-market sale of 21,350 shares of common stock at a weighted average price of $13.2805 per share. After this sale, he directly holds 366,288 shares, plus 318 shares held indirectly through a 401(k) plan, indicating he retains a substantial position.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Campbell Paul

(Last)(First)(Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PENNSYLVANIA 15317

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/23/2026S21,350D$13.2805(1)366,288D
Common Stock318IBy 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the weighted average price of the reporting person's disposition of 21,350 shares of common stock in transactions ranging from $13.205 to $13.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Remarks:
Chief Accounting Officer and Corporate Controller
/s/ Kevin Macikowski, by power of attorney03/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Viatris (VTRS) report for Paul Campbell?

Paul Campbell reported selling 21,350 shares of Viatris common stock in an open-market transaction. The weighted average sale price was $13.2805 per share, based on trades executed between $13.205 and $13.34 during the reported date.

At what price did Paul Campbell sell Viatris (VTRS) shares?

The reported weighted average sale price was $13.2805 per Viatris share. Individual trades occurred at prices ranging from $13.205 to $13.34, with the insider offering to provide full breakdowns of shares sold at each separate price upon request.

How many Viatris (VTRS) shares does Paul Campbell hold after this sale?

After the reported sale, Paul Campbell directly holds 366,288 shares of Viatris common stock. He also has an additional 318 shares held indirectly through a 401(k) plan, reflecting both direct ownership and retirement-plan exposure to the stock.

Was the Viatris (VTRS) insider transaction an open-market sale?

Yes. The filing classifies the transaction as an open-market sale of common stock. The sale used transaction code “S,” which indicates a sale in the open market or a private transaction, with a disclosed weighted average sale price for the shares.

Does the Viatris (VTRS) Form 4 show any option exercises or derivative trades?

No derivative option exercises are shown in this Form 4. The filing reports one non-derivative open-market sale of common stock and a separate holding entry for 318 shares held indirectly via a 401(k) plan, with no derivative positions listed afterward.
Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

15.38B
1.15B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG